Paper22673249
Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock.
Tapia P and 4 others. J Trauma Acute Care Surg, 2012. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock. Papers, record 22673249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22673249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemodynamics | Major topic |
| Hemofiltration | Major topic |
| Shock, Septic | Major topic |
| Chile | |
| Female | |
| Follow-Up Studies | |
| Hospital Mortality | |
| Humans | |
| Intensive Care Units | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Respiratory Function Tests | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979081 | Hemodynamic response to high-volume hemofiltration in pediatric septic shock. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42979081 | PubMed |
| 40613773 | Continuous Renal Replacement Therapy: Application of Kidney Disease Improving Global Outcomes Guidelines for Treatment Prescription in Dogs With Acute Kidney Injury and Outcome Prediction. | J Vet Intern Med | 2025 | https://conductscience.org/library/papers/40613773 | PubMed |
| 39722012 | Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives. | Crit Care | 2024 | https://conductscience.org/library/papers/39722012 | PubMed |
| 37034019 | Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements. | World J Crit Care Med | 2023 | https://conductscience.org/library/papers/37034019 | PubMed |
| 36978907 | Effect of Dietary Supplements with ω-3 Fatty Acids, Ascorbic Acid, and Polyphenolic Antioxidant Flavonoid on Gene Expression, Organ Failure, and Mortality in Endotoxemia-Induced Septic Rats. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36978907 | PubMed |
| 36552677 | Oxidized High-Density Lipoprotein Induces Endothelial Fibrosis Promoting Hyperpermeability, Hypotension, and Increased Mortality. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36552677 | PubMed |
| 35693122 | Blood purification for sepsis: an overview. | Precis Clin Med | 2021 | https://conductscience.org/library/papers/35693122 | PubMed |
| 33710670 | Targeted high volume hemofiltration could avoid extracorporeal membrane oxygenation in some patients with severe Hantavirus cardiopulmonary syndrome. | J Med Virol | 2021 | https://conductscience.org/library/papers/33710670 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22673249
GET https://conductscience.org/api/papers/v1/22673249/authors